← Back
$SYRE All transactions

Spyre Therapeutics, Inc.

A

$ Value

$0

Shares

25,000

Price

$0

Filed

Jun 2

Insider

Name

McKenna Mark C.

Title

CIK

0001749623

Roles

Director

Transaction Details

Transaction Date

2025-05-29

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

25,000

Footnotes

This option represents a right to purchase 25,000 shares of the Issuer's common stock, which will vest and become exercisable in 12 equal monthly installments following May 29, 2025 until such time as the option is 100% vested, subject to the Reporting Person's continuous service with the Issuer at each vesting date.

Filing Info

Accession No.

0001636282-25-000066

Form Type

4

Issuer CIK

0001636282

McKenna Mark C.'s History

Date Ticker Type Value
2025-08-11 BBOT M
2025-08-11 BBOT M $0
2025-06-17 APGE A $0
2025-05-29 SYRE A $0

Other Insiders at SYRE (90d)

Insider Bought Sold Last
Turtle Cameron
Chief Executive Officer
$740K 2026-04-01
Burrows Scott L
Chief Financial Officer
$370K 2026-04-01
Sloan Sheldon
Chief Medical Officer
$398K 2026-04-01